B-cells and mixed cryoglobulinemia-Reference-Cited by-同舟云学术

B-cells and mixed cryoglobulinemia

Published:2007-12 Issue:2 Volume:7 Page:114-120
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Ferri Clodoveo,Antonelli Alessandro,Mascia Maria Teresa,Sebastiani Marco,Fallahi Poupak,Ferrari Daniela,Giunti Marco,Pileri Stefano A.,Zignego Anna Linda

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Mixed cryoglobulinemia cross-reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases;Gorevic;Semin Hematol,1991

2. Biologic and clinical significance of cryoglobulins;Brouet;Am J Med,1974

3. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity;Meltzer;Am J Med,1966

4. Cryoglobulins;Ferri;J Clin Pathol,2002

5. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma;De Vita;Arthritis Rheum,2000

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mixed cryoglobulinaemia vasculitis secondary to marginal zone lymphoma in a patient with end-stage renal failure on haemodialysis;CEN Case Reports;2023-10-06

2. COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity;Journal of Clinical Immunology;2023-02-16

3. Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions;Scientific Reports;2022-09-01

4. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life;Autoimmunity Reviews;2022-01

5. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy;Minerva Medica;2021-04